Atrial fibrillation Trials in Hammond, United States
Conditions / Atrial fibrillation / Hammond, United States
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT00559988 | Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk | TERMINATED | PHASE4 |
| NCT01701817 | Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) | COMPLETED | — |
| NCT05130268 | Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation | COMPLETED | PHASE4 |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT01165710 | Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) | COMPLETED | — |
| NCT00627328 | The Atrial High Rate Episodes in Pacemaker Patients | COMPLETED | — |
| NCT01468701 | GLORIA-AF Registry Program - Second and Third Phases | COMPLETED | — |
| NCT01493557 | A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation | COMPLETED | PHASE4 |